These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28093969)

  • 1. Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches.
    Kaijzel EL; van Beek ER; Stammes MA; Que I; Chan AB; Lowik CWGM; Cruz LJ
    Curr Pharm Des; 2017; 23(13):1909-1915. PubMed ID: 28093969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in nanomedicine development for traumatic brain injury.
    Ling Y; Ramalingam M; Lv X; Zeng Y; Qiu Y; Si Y; Pedraz JL; Kim HW; Hu J
    Tissue Cell; 2023 Jun; 82():102087. PubMed ID: 37060747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal therapeutics in the management of traumatic brain injury: Portray of biomarkers and drug-targets, preclinical and clinical pieces of evidence and future prospects.
    Arya S; Bahuguna D; Bajad G; Loharkar S; Devangan P; Khatri DK; Singh SB; Madan J
    Colloids Surf B Biointerfaces; 2023 Oct; 230():113509. PubMed ID: 37595379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury.
    Khalin I; Alyautdin R; Wong TW; Gnanou J; Kocherga G; Kreuter J
    Drug Deliv; 2016 Nov; 23(9):3520-3528. PubMed ID: 27278330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature vs. Manmade: Comparing Exosomes and Liposomes for Traumatic Brain Injury.
    Hennigan K; Lavik E
    AAPS J; 2023 Aug; 25(5):83. PubMed ID: 37610471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Happens in TBI? A Wide Talk on Animal Models and Future Perspective.
    Kundu S; Singh S
    Curr Neuropharmacol; 2023; 21(5):1139-1164. PubMed ID: 35794772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vision impairment after traumatic brain injury: present knowledge and future directions.
    Das M; Tang X; Mohapatra SS; Mohapatra S
    Rev Neurosci; 2019 Apr; 30(3):305-315. PubMed ID: 30226209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy.
    Kochanek PM; Bramlett HM; Dixon CE; Shear DA; Dietrich WD; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC
    J Neurotrauma; 2016 Mar; 33(6):513-22. PubMed ID: 26439468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Traumatic Brain Injury in the Preclinical Setting.
    Berkner J; Mannix R; Qiu J
    Methods Mol Biol; 2016; 1462():11-28. PubMed ID: 27604710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats.
    Wali B; Sayeed I; Guthrie DB; Natchus MG; Turan N; Liotta DC; Stein DG
    Neuropharmacology; 2016 Oct; 109():148-158. PubMed ID: 27267687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine.
    Hoffer BJ; Pick CG; Hoffer ME; Becker RE; Chiang YH; Greig NH
    J Biomed Sci; 2017 Sep; 24(1):71. PubMed ID: 28886718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-Infrared Spectroscopy: A Promising Prehospital Tool for Management of Traumatic Brain Injury.
    Peters J; Van Wageningen B; Hoogerwerf N; Tan E
    Prehosp Disaster Med; 2017 Aug; 32(4):414-418. PubMed ID: 28351447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer and nano-technology applications for repair and reconstruction of the central nervous system.
    Cho Y; Borgens RB
    Exp Neurol; 2012 Jan; 233(1):126-44. PubMed ID: 21985867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury.
    Haroon K; Zheng H; Wu S; Liu Z; Tang Y; Yang GY; Liu Y; Zhang Z
    Int J Pharm; 2024 Jan; 649():123656. PubMed ID: 38040392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Global Pediatric Traumatic Brain Injury: Qualitative Review.
    Dewan MC; Mummareddy N; Wellons JC; Bonfield CM
    World Neurosurg; 2016 Jul; 91():497-509.e1. PubMed ID: 27018009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanine Nanocage Activated by Near-IR Light for the Targeted Delivery of Cyclosporine A to Traumatic Brain Injury Sites.
    Black CE; Zhou E; DeAngelo C; Asante I; Yang R; Petasis NA; Louie SG; Humayun M
    Mol Pharm; 2020 Dec; 17(12):4499-4509. PubMed ID: 32813533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation Therapy in Traumatic Brain Injury.
    Tykocki T; Guzek K
    World Neurosurg; 2016 May; 89():497-504. PubMed ID: 26850974
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.